2025 annual financial data
Q32 Bio 2025 Operating margin
Direct answer
Operating margin was 31.45%.
Operating income was 16,902,000 USD and net income was 29,821,000 USD.
Operating cash flow was -33,543,000 USD.
Get free Q32 Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 53,737,000 USD
- Operating income
- 16,902,000 USD
- Net income
- 29,821,000 USD
- Operating cash flow
- -33,543,000 USD